Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure
- 1 May 1981
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 101 (5), 534-540
- https://doi.org/10.1016/0002-8703(81)90218-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Long-term therapy of heart failure with prazosin: A randomized double blind trialThe American Journal of Cardiology, 1980
- Development of pharmacodynamic tolerance to prazosin in congestive heart failureThe American Journal of Cardiology, 1979
- Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failureThe American Journal of Cardiology, 1979
- Attenuation of Prazosin Effect on Cardiac Output in Chronic Heart FailureAnnals of Internal Medicine, 1979
- Prazosin determination by high-pressure liquid chromatography using flourescence detectionJournal of Chromatography A, 1979
- Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.Circulation, 1979
- Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failureAmerican Journal Of Medicine, 1978
- Development of systemic vasodilator tolerance to prazosin with chronic use of the agent in ambulatory therapy of severe congestive heart failureThe American Journal of Cardiology, 1978
- Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.Circulation, 1977
- Sustained Reduction of Cardiac Impedance and Preload in Congestive Heart Failure with the Antihypertensive Vasodilator PrazosinNew England Journal of Medicine, 1977